Baxter Healthcare Corporation recalls Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx o
Recalled November 18, 2020 · FDA recall D-0076-2021 · Baxter Healthcare
Hazard
Presence of particulate matter in solution - black and transparent particles · FDA Class II
Sold at
Nationwide USA
Description
Presence of particulate matter in solution - black and transparent particles
Product
Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10
Manufacturer(s)
Baxter Healthcare Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →